Antimicrobial Agents Practice Questions

Q: In areas with chloroquine-sensitive P. vivax, what is the preferred drug for treating the blood stages?

Chloroquine. ***Correct Option: Chloroquine***- **Chloroquine** remains the **first-line treatment** for **chloroquine-sensitive P. vivax** infections due to its high efficacy and safety profile [1, 2].- It rapidly clears **blood-stage parasites**, alleviating acute symptoms of malaria [3].- In areas where P. vivax remains sensitive, chloroquine is preferred due to low cost, good tolerability, and proven effectiveness [1, 2].*Incorrect Option: Mefloquine*- **Mefloquine** is typically reserved for areas with **chloroquine-resistant P. falciparum** or for prophylaxis in such regions.- Its use is generally avoided when less toxic and equally effective options like chloroquine are available for sensitive strains.- Associated with more neuropsychiatric side effects.*Incorrect Option: Artesunate*- **Artesunate** is an **artemisinin derivative**, primarily used for severe malaria or in areas with **multi-drug resistant P. falciparum**.- While effective, it is not the preferred first-line agent for chloroquine-sensitive P. vivax due to the availability of simpler, equally effective treatments.- Typically used in combination therapy (ACT) for resistant strains.*Incorrect Option: Quinine*- **Quinine** is an older antimalarial, often used for **severe malaria** or in cases of **chloroquine-resistant P. falciparum**.- It has a higher incidence of side effects compared to chloroquine (cinchonism, hypoglycemia) and is not the preferred choice for chloroquine-sensitive P. vivax.- Requires longer treatment duration with more monitoring.

Q: Emtricitabine is classified as which of the following?

NRTI. ***NRTI*** - Emtricitabine is a **nucleoside reverse transcriptase inhibitor (NRTI)**, a class of antiretroviral drugs used in the treatment of **HIV infection**. - As an NRTI, it works by inhibiting the enzyme **reverse transcriptase**, which is crucial for the HIV virus to replicate its RNA into DNA. *Alkylating agent* - Alkylating agents are a type of **chemotherapy drug** that kill cancer cells by damaging their DNA. - They are primarily used in **cancer treatment**, not for viral infections like HIV. *Antimetabolite* - Antimetabolites are drugs that interfere with DNA and RNA synthesis, often used in **chemotherapy** to treat cancer or in immunosuppression. - While they can inhibit nucleic acid synthesis, this is a broad category, and emtricitabine's specific mechanism and classification are as an NRTI. *Integrase Inhibitor* - Integrase inhibitors are another class of **antiretroviral drugs** that block the HIV enzyme integrase, preventing the viral DNA from integrating into the host cell's DNA. - While an antiretroviral, emtricitabine has a different mechanism of action and belongs to the NRTI class.

Q: Which drug is linked to hypertrophic pyloric stenosis in infants?

Erythromycin. ***Erythromycin*** - Studies have shown an association between infantile exposure to **erythromycin** and an increased risk of developing **hypertrophic pyloric stenosis**. - This risk is particularly noted when erythromycin is administered during the **first two weeks of life**, possibly due to its potent motilin receptor agonism. *Tetracycline* - **Tetracycline** is known for causing **teeth discoloration** and **bone growth retardation** in infants and children. - It is generally contraindicated in pediatric populations due to these significant side effects, but it is not linked to pyloric stenosis. *Ampicillin* - **Ampicillin** is a penicillin antibiotic commonly used in infants for bacterial infections. - While it can cause side effects like **rashes** and **diarrhea**, there is no established link to hypertrophic pyloric stenosis. *Rifampicin* - **Rifampicin** is an antibiotic primarily used for treating tuberculosis. - Its main side effects include **hepatotoxicity** and **red-orange discoloration of body fluids**, but it has no known association with hypertrophic pyloric stenosis.

Q: Which of the following is not excreted by the kidney?

Moxifloxacin. ***Moxifloxacin*** - Moxifloxacin is primarily metabolized in the **liver** and excreted through bile and feces. - This characteristic makes it a suitable choice for patients with significant **renal impairment** as dose adjustments are generally not required. *Ciprofloxacin* - Ciprofloxacin is predominantly excreted by the **kidneys** through both glomerular filtration and tubular secretion. - Dose adjustments are crucial in patients with **renal dysfunction** to prevent accumulation and toxicity. *Ofloxacin* - Ofloxacin is largely excreted unchanged in the **urine**, making renal excretion its primary elimination pathway. - **Dose reduction** is necessary for patients with impaired renal function. *Levofloxacin* - Levofloxacin is primarily eliminated via **renal excretion**, with a significant portion appearing in the urine as unmetabolized drug. - Patients with **kidney disease** require appropriate dose adjustments.

Q: Which of the following combinations does not show synergistic action?

Penicillin plus tetracycline. ***Penicillin plus tetracycline*** - This combination is generally **antagonistic** or **indifferent**, not synergistic. Penicillin is a cell wall synthesis inhibitor that works best on actively growing bacteria, while tetracycline is a bacteriostatic protein synthesis inhibitor that can reduce bacterial growth, thereby diminishing penicillin's effect. - The combination is usually avoided as the **bacteriostatic action of tetracycline** can counteract the **bactericidal action of penicillin**, leading to reduced efficacy, especially in infections requiring rapid bacterial clearance. *Penicillin plus sulfonamide* - This combination can show synergism in some contexts, particularly as sulfonamides inhibit **folate synthesis**, while penicillin inhibits **cell wall synthesis**. - While not a classic synergistic pair for all infections, their mechanisms of action are distinct, and they can sometimes be used together, although specific synergistic effects are more limited compared to other pairs. *Streptomycin plus penicillin* - This is a classic example of **synergistic action**, particularly in conditions like **enterococcal endocarditis**. - Penicillin damages the bacterial cell wall, allowing **streptomycin** (an aminoglycoside) to more easily penetrate the cell and act on ribosomal targets, leading to enhanced bactericidal effect. *Rifampicin plus dapsone* - This combination is a cornerstone of **multi-drug therapy for leprosy**, demonstrating clear synergy against *Mycobacterium leprae*. - **Rifampicin** inhibits bacterial RNA synthesis, and **dapsone** inhibits folate synthesis, attacking different essential bacterial pathways which, when combined, are more effective and reduce the development of resistance.

Q: Which of the following conditions is not associated with an increased risk of neuropathy caused by Isoniazid (INH)?

Hyperthyroidism. ***Hyperthyroidism*** - **Hyperthyroidism** is not typically associated with an increased risk of isoniazid-induced neuropathy. The neuropathy due to INH is primarily linked to **pyridoxine (vitamin B6) deficiency**. - While hyperthyroidism can cause its own set of neurological symptoms, it does not directly impair pyridoxine metabolism or exacerbate INH's neurotoxic effects. *Uremia* - **Uremia** (renal failure) can increase the risk of INH-induced neuropathy due to impaired drug excretion, leading to higher plasma concentrations of INH and its metabolites. - Patients with uremia often have compromised nutritional status and may experience vitamin deficiencies, further contributing to pyridoxine depletion. *Diabetes mellitus* - **Diabetes mellitus** is a significant risk factor for INH-induced neuropathy because it is an independent cause of **peripheral neuropathy** itself, making patients more susceptible to additional nerve damage. - Diabetic patients may also have altered pyridoxine metabolism or suboptimal nutritional intake, predisposing them to INH toxicity. *Poor nutrition* - **Poor nutrition**, particularly malabsorption or inadequate dietary intake, directly contributes to **pyridoxine (vitamin B6) deficiency**. - Isoniazid's mechanism of neurotoxicity involves interfering with pyridoxine metabolism, so pre-existing deficiency significantly increases the risk of neuropathy.

Q: Which of the following is the longest acting carbapenem?

Ertapenem. ***Ertapenem*** - **Ertapenem** has the **longest half-life** among the carbapenems, allowing for once-daily dosing. - Its prolonged action is due to its **chemical structure**, which provides high protein binding and reduced renal clearance compared to other carbapenems. *Imipenem* - **Imipenem** has a **relatively short half-life** and requires co-administration with cilastatin to prevent its renal metabolism by dehydropeptidase-1. - Its short duration of action necessitates **frequent dosing**, typically every 6 to 8 hours. *Meropenem* - **Meropenem** has a **shorter half-life** than ertapenem, generally requiring dosing every 8 hours. - Although it does not require cilastatin, its pharmacokinetic profile is not as extended as ertapenem's. *Doripenem* - **Doripenem** also has a **shorter half-life** than ertapenem, necessitating administration every 8 hours. - Its spectrum of activity is similar to meropenem, but it does not offer the same extended duration of action.

Q: Thymidine is responsible for resistance to which antibiotic ?

Sulfonamide. ***Sulfonamide*** - **Thymidine** can contribute to **sulfonamide resistance** because sulfonamides interfere with **folate metabolism** and the subsequent synthesis of purines and pyrimidines, including thymidine. - An excess of thymidine can bypass the metabolic block caused by sulfonamides, allowing bacteria to continue DNA synthesis and grow. *Erythromycin* - **Erythromycin** resistance is primarily mediated by **methylation of ribosomal RNA**, which prevents the antibiotic from binding to the 50S ribosomal subunit. - It does not directly involve thymidine or the folate synthesis pathway. *Tetracycline* - Resistance to **tetracyclines** is commonly due to **efflux pumps** that actively pump the drug out of the bacterial cell or **ribosomal protection proteins** that prevent tetracycline binding. - Thymidine production or metabolism is not a mechanism of tetracycline resistance. *Nitrofurantoin* - **Nitrofurantoin** resistance typically involves **mutations** in bacterial enzymes (like **nitrofuran reductase**) that are responsible for activating the drug into its active form. - These mutations prevent the drug from becoming bactericidal, and thymidine does not play a role in this mechanism.

Q: Which of the following is a primary use of Levamisole?

Antihelminthic. ***Antihelminthic*** - Levamisole is **primarily classified as an antihelminthic drug**, used to treat parasitic worm infections. - It acts as a **nicotinic receptor agonist** in nematodes, causing spastic paralysis of the worms, leading to their expulsion. - It was historically used in humans for treating ascariasis and hookworm infections, and is still used in **veterinary medicine** for deworming livestock. - This is its **primary pharmacological classification** in standard medical textbooks. *Immunomodulator* - Levamisole does have **immunomodulatory properties** that were discovered secondary to its antihelminthic use. - It was used as **adjuvant therapy in colon cancer** (with 5-FU) to enhance immune response. - However, this is a **secondary use**, not its primary classification, and has been largely discontinued due to severe side effects like agranulocytosis. *Immunostimulant* - While levamisole can stimulate certain aspects of cell-mediated immunity, this overlaps with its immunomodulatory effects. - This is **not its primary pharmacological classification** - it remains primarily an antihelminthic agent. *None of the options* - This is incorrect because **antihelminthic** is clearly the primary and correct classification of levamisole in pharmacology. - Its antihelminthic action was its original and primary therapeutic application.

Q: Idoxuridine is used for treatment of?

HSV. ***HSV*** - **Idoxuridine** is a **pyrimidine analog** that inhibits viral DNA synthesis, making it effective against **herpes simplex virus (HSV)** infections, particularly **herpes keratitis** (ophthalmic use). - Its mechanism involves being incorporated into viral DNA, leading to errors in replication and transcription. - It is applied **topically** for ocular HSV infections due to systemic toxicity concerns. *Influenza* - **Idoxuridine** is not active against **influenza viruses**. - **Antiviral drugs** like **oseltamivir** or **zanamivir** are typically used for influenza treatment. *RSV* - **Idoxuridine** is not indicated for the treatment of **respiratory syncytial virus (RSV)**. - **Ribavirin** is the primary antiviral agent used for severe RSV infections, especially in immunocompromised patients. *HIV* - **Idoxuridine** has no significant activity against **human immunodeficiency virus (HIV)**. - **Antiretroviral therapy (ART)**, a combination of drugs targeting various stages of the HIV life cycle, is used for HIV treatment.

Question 1

In areas with chloroquine-sensitive P. vivax, what is the preferred drug for treating the blood stages?

Accepted Answer

Chloroquine

Answer

Mefloquine

Answer

Artesunate

Answer

Quinine

Question 2

Emtricitabine is classified as which of the following?

Accepted Answer

NRTI

Answer

Alkylating agent

Answer

Antimetabolite

Answer

Integrase Inhibitor

Question 3

Which drug is linked to hypertrophic pyloric stenosis in infants?

Accepted Answer

Erythromycin

Answer

Ampicillin

Answer

Rifampicin

Answer

Tetracycline

Question 4

Which of the following is not excreted by the kidney?

Accepted Answer

Moxifloxacin

Answer

Ciprofloxacin

Answer

Ofloxacin

Answer

Levofloxacin

Question 5

Which of the following combinations does not show synergistic action?

Accepted Answer

Penicillin plus tetracycline

Answer

Streptomycin plus penicillin

Answer

Rifampicin plus dapsone

Answer

Penicillin plus sulfonamide

Question 6

Which of the following conditions is not associated with an increased risk of neuropathy caused by Isoniazid (INH)?

Accepted Answer

Hyperthyroidism

Answer

Uremia

Answer

Diabetes mellitus

Answer

Poor nutrition

Question 7

Which of the following is the longest acting carbapenem?

Accepted Answer

Ertapenem

Answer

Imipenem

Answer

Meropenem

Answer

Doripenem

Question 8

Thymidine is responsible for resistance to which antibiotic ?

Accepted Answer

Sulfonamide

Answer

Erythromycin

Answer

Tetracycline

Answer

Nitrofurantoin

Question 9

Which of the following is a primary use of Levamisole?

Accepted Answer

Antihelminthic

Answer

Immunostimulant

Answer

None of the options

Answer

Immunomodulator

Question 10

Idoxuridine is used for treatment of?

Accepted Answer

HSV

Answer

Influenza

Answer

RSV

Answer

HIV

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?